Jean Scheftsik de Szolnok (@Jean2S) / Twitter
Boehringer Ingelheim Venture Fund | Imprint
Boehringer Ingelheim's Board of Managing Directors | Boehringer Ingelheim
Jean Scheftsik de Szolnok nommé Président du groupe Boehringer Ingelheim France | boehringer-ingelheim.fr
Boehringer y Ashoka invitan a imaginar modelos de negocio innovadores en salud
Boehringer Ingelheim's Board of Managing Directors | Boehringer Ingelheim
Boehringer pharma chief heads for the exit amid a top-level reshuffling | FiercePharma
sustainably fighting rabies info hub | Boehringer Ingelheim
Boehringer Ingelheim baut RCV weiter aus
Interview with Jean Scheftsik de Szolnok, Boehringer Ingelheim
BI Search | Boehringer Ingelheim
Boehringer Ingelheim on Twitter: "¡Agéndalo! 🗓 El lunes 26 de octubre, Jean Scheftsik de Szolnok (@Jean2S) se presentará en el @WorldHealthSmt. Junto a líderes globales disertará sobre el potencial de #OneHealth para
The Lancet One Health Commission at the 2020 World Health Summit - Institute of Health and Society
Jean Scheftsik de Szolnok - Member of the Board of Managing Directors and Head of the Animal Health Business Unit - Boehringer Ingelheim | LinkedIn
Boehringer Ingelheim's Board of Managing Directors | Boehringer Ingelheim
Boehringer Ingelheim - Drug Discovery and Development
Press Kit Animal Health | Boehringer Ingelheim
Jean Scheftsik de Szolnok - Member of the Board of Managing Directors and Head of the Animal Health Business Unit - Boehringer Ingelheim | LinkedIn
Jean de Szolnok | Les Echos
Boehringer Ingelheim chops 295 jobs in France but vows $380M in animal health investments | FiercePharma
Santé : Un nouveau président pour Boehringer Ingelheim France
Boehringer Ingelheim beginnt mit dem Bau seines künftigen Produktionszentrums für Veterinärimpfstoffe – Acteurs du franco-allemand
Jean Scheftsik de Szolnok - Member of the Board of Managing Directors and Head of the Animal Health Business Unit - Boehringer Ingelheim | LinkedIn
